GLOBAL HEALTH & PHARMA
GHP is a global information sharing platform & a multi-disciplinary members community. Established to enhance communication networks & collaboration across all themes and disciplines within 3 main categories; Human, Animal & Environmental Health. Whilst the membership is organically grown and closely audited, members have tended to fall into a number of general categories; Academia, Industry, Public Bodies & Health Systems, Governments & Policy Makers, Funding Agencies & Groups, Investors, Regulatory & Professional Bodies, a more detailed breakdown can be found under circulation.
GLOBAL HEALTH & PHARMA
Industry:
Publishing
Status:
Active
Contact:
+44 (0) 203 725 6847
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Apache Global Site Tag
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-01-13 | Pregistry | Global Health & Pharma investment in Grant - Pregistry | N/A |
More informations about "Global Health & Pharma"
World Health Organization (WHO)
Second meeting of the International Health Regulations (2005) Emergency Committee regarding the upsurge of mpox 2024. 26 November 2024. ... News release. The first-ever global oral …See details»
IFPMA - Innovating to improve health worldwide
4 days ago The Biopharmaceutical CEO Roundtable (BCR), which represents the world’s leading biopharmaceutical companies, met in New York City, on 21 November, to discuss …See details»
Health products policy and standards - World Health …
May 15, 2019 The norms and standards for pharmaceuticals developed by WHO are prepared through a vast global consultative process involving WHO Member States, national regulatory authorities and international agencies; in …See details»
Global Health Impact
The Global Health Impact Index – supported by a collaboration of researchers from universities and civil society organizations around the world – opens the door to positive change by measuring pharmaceutical products’ impact on …See details»
Global Health and Healthcare Strategic Outlook: Shaping the …
Nov 8, 2022 the pandemic response as part of our global health and healthcare systems moving forward. Global health and healthcare will face important challenges in the future. In the near …See details»
Access to medicines and health products - World …
Oct 10, 2024 Universal health coverage can only be achieved when there is affordable access to safe, effective and quality medicines and health products. Countries face a range of obstacles to achieving this, including rising prices …See details»
The PharmaceuTical indusTry and Global healTh: FacTs and FiGures
14 The Pharmaceutical Industry and Global Health: Facts and Figures Pharmaceutical innovation and public health 15 models to foster innovation.7 In 2007 alone, the pharmaceutical industry …See details»
Home Page - Global Health Progress
Global Health Progress is an interactive resource hub highlighting collaborations between the innovative pharmaceutical industry and our global stakeholders to support the SDGs. Overview; SDGS In Focus. SDG 3: Good Health and Well …See details»
Facts and Figures 2022: The Pharmaceutical Industry …
Sep 20, 2022 Biopharmaceutical CEO Roundtable meets in New York, focusing on challenges and opportunities, role of pharmaceutical innovation. The Biopharmaceutical CEO Roundtable (BCR), which represents the world’s …See details»
The Global Use of Medicines 2024: Outlook to 2028
Jan 16, 2024 <p> With the World Health Organization’s declaration on May 5, 2023, of the end of the COVID-19 public health emergency, attention has shifted to the prevention and treatment of other communicable diseases as …See details»
Global health - Novartis
At Novartis, we have a long-standing history in addressing global health challenges. Over the past 20 years, our approach has evolved from purely donation-based toward models with more …See details»
Why pharmaceuticals and public healthcare systems must work …
Jan 16, 2023 Both public health systems and pharmaceutical companies must adapt and re-focus on patients ... COVID-19 may still consume much of the attention of the global health …See details»
The role for pharma companies in addressing global public health ...
Jun 12, 2018 Today, our Global Public Health organization sits between our commercial business and our philanthropic work—a first-of-its-kind model. Our unit’s purpose is to make …See details»
Global health partnerships - World Health Organization (WHO)
Global health partnerships, such as the Global Fund to Fight AIDS, Tuberculosis and Malaria, and GAVI, the Vaccine Alliance, were established to streamline efforts in the health sector and …See details»
What is global health? Key concepts and clarification of …
Apr 7, 2020 Our current understanding of the concept of global health is based on information in the literature in the past seven to eight decades. Global health as a scientific term first …See details»
Access to medicines through global health diplomacy - PMC
Keywords: Health equity, Access to medicines, Sustainable development goals, Global health, Diplomacy, Security measures, COVID-19, Vaccines, Pharmaceuticals Introduction The …See details»
What are the obligations of pharmaceutical companies in a global …
Sep 11, 2021 During a global health emergency, everyone is morally required to help to combat the disease. With approximately 8000–10 000 people dying every day from COVID-19, as of …See details»
Join the global effort in strengthening local production for health ...
1 day ago The overarching theme of the 3 rd WLPF, “Advancing Local Production for Health Equity, Global Health Security, and Sustainable Development”, highlights the forum’s …See details»
Global health - GSK
As a result of our collaborative approach to global health R&D, and alongside our ground-breaking scientific innovations for malaria, TB, HIV and other priority global health diseases, we are …See details»
Chinese Pharma: A Global Health Game Changer?
China’s Pharmaceutical Boom. More on: China. Pharmaceuticals and Vaccines. Health. Development. During the Mao era (1949–76), China’s weak R&D capacity and decades of …See details»